Diabetes is a chronic disease that affects millions of people worldwide. It occurs when the body is unable to produce or use insulin effectively, leading to high levels of glucose in the blood. This can cause a range of health problems, including heart disease, nerve damage, kidney disease, and vision loss. Stem cell therapy is a new and rapidly evolving field of medicine that holds promise for treating a range of conditions, including diabetes. The idea behind stem cell therapy is to replace damaged or diseased cells with new, healthy cells to help restore normal functioning to the body. One type of stem cell therapy for diabetes involves the use of mesenchymal stem cells (MSCs). MSCs are a type of stem cell that can differentiate into various cell types, including insulin-producing beta cells. In the case of diabetes, MSCs are injected into the body to help replace damaged beta cells and improve insulin production. There have been several clinical trials evaluating the use of MSCs fo